nodes	percent_of_prediction	percent_of_DWPC	metapath
Enzalutamide—AR—breast cancer	0.14	0.397	CbGaD
Enzalutamide—AR—Fluoxymesterone—breast cancer	0.0827	0.187	CbGbCtD
Enzalutamide—CYP2D6—breast cancer	0.064	0.182	CbGaD
Enzalutamide—CYP3A4—breast cancer	0.0549	0.156	CbGaD
Enzalutamide—ALB—breast cancer	0.0479	0.136	CbGaD
Enzalutamide—ABCB1—breast cancer	0.0457	0.13	CbGaD
Enzalutamide—CYP2B6—Thiotepa—breast cancer	0.0198	0.0448	CbGbCtD
Enzalutamide—CYP2C9—Anastrozole—breast cancer	0.0138	0.0312	CbGbCtD
Enzalutamide—CYP3A5—Lapatinib—breast cancer	0.0137	0.0311	CbGbCtD
Enzalutamide—CYP2B6—Raloxifene—breast cancer	0.0132	0.0299	CbGbCtD
Enzalutamide—CYP2C8—Lapatinib—breast cancer	0.0132	0.0299	CbGbCtD
Enzalutamide—ABCB1—Toremifene—breast cancer	0.0123	0.0277	CbGbCtD
Enzalutamide—CYP2C19—Lapatinib—breast cancer	0.0111	0.0251	CbGbCtD
Enzalutamide—CYP3A4—Exemestane—breast cancer	0.0106	0.024	CbGbCtD
Enzalutamide—CYP2C9—Idarubicin—breast cancer	0.0105	0.0237	CbGbCtD
Enzalutamide—CYP2C8—Raloxifene—breast cancer	0.01	0.0226	CbGbCtD
Enzalutamide—CYP2D6—Idarubicin—breast cancer	0.00957	0.0216	CbGbCtD
Enzalutamide—CYP3A4—Letrozole—breast cancer	0.00901	0.0204	CbGbCtD
Enzalutamide—ABCB1—Lapatinib—breast cancer	0.00894	0.0202	CbGbCtD
Enzalutamide—CYP2B6—Tamoxifen—breast cancer	0.00873	0.0197	CbGbCtD
Enzalutamide—CYP3A4—Anastrozole—breast cancer	0.00803	0.0182	CbGbCtD
Enzalutamide—CYP3A4—Toremifene—breast cancer	0.00734	0.0166	CbGbCtD
Enzalutamide—CYP3A5—Tamoxifen—breast cancer	0.00688	0.0156	CbGbCtD
Enzalutamide—CYP3A4—Fulvestrant—breast cancer	0.00683	0.0154	CbGbCtD
Enzalutamide—CYP2B6—Irinotecan—breast cancer	0.0067	0.0152	CbGbCtD
Enzalutamide—CYP2C8—Tamoxifen—breast cancer	0.00661	0.015	CbGbCtD
Enzalutamide—ALB—Irinotecan—breast cancer	0.00657	0.0149	CbGbCtD
Enzalutamide—ALB—Fluorouracil—breast cancer	0.00631	0.0143	CbGbCtD
Enzalutamide—CYP3A4—Thiotepa—breast cancer	0.00608	0.0138	CbGbCtD
Enzalutamide—CYP2C9—Capecitabine—breast cancer	0.00573	0.013	CbGbCtD
Enzalutamide—CYP3A4—Ixabepilone—breast cancer	0.00556	0.0126	CbGbCtD
Enzalutamide—CYP2C19—Tamoxifen—breast cancer	0.00555	0.0125	CbGbCtD
Enzalutamide—CYP3A4—Lapatinib—breast cancer	0.00536	0.0121	CbGbCtD
Enzalutamide—CYP3A5—Paclitaxel—breast cancer	0.00535	0.0121	CbGbCtD
Enzalutamide—CYP3A5—Irinotecan—breast cancer	0.00528	0.0119	CbGbCtD
Enzalutamide—CYP2C8—Paclitaxel—breast cancer	0.00515	0.0116	CbGbCtD
Enzalutamide—ABCB1—Vinorelbine—breast cancer	0.00496	0.0112	CbGbCtD
Enzalutamide—CYP2C8—Fluorouracil—breast cancer	0.00487	0.011	CbGbCtD
Enzalutamide—CYP2D6—Vinorelbine—breast cancer	0.00467	0.0106	CbGbCtD
Enzalutamide—CYP2C9—Tamoxifen—breast cancer	0.00461	0.0104	CbGbCtD
Enzalutamide—ABCB1—Tamoxifen—breast cancer	0.00448	0.0101	CbGbCtD
Enzalutamide—ABCB1—Mitoxantrone—breast cancer	0.00437	0.00987	CbGbCtD
Enzalutamide—CYP2D6—Tamoxifen—breast cancer	0.00422	0.00954	CbGbCtD
Enzalutamide—CYP3A4—Raloxifene—breast cancer	0.00406	0.00918	CbGbCtD
Enzalutamide—CYP3A5—Docetaxel—breast cancer	0.00387	0.00875	CbGbCtD
Enzalutamide—ABCB1—Gemcitabine—breast cancer	0.00386	0.00872	CbGbCtD
Enzalutamide—CYP2B6—Doxorubicin—breast cancer	0.00366	0.00828	CbGbCtD
Enzalutamide—CYP2C9—Paclitaxel—breast cancer	0.00359	0.00812	CbGbCtD
Enzalutamide—ABCB1—Paclitaxel—breast cancer	0.00348	0.00788	CbGbCtD
Enzalutamide—ALB—Methotrexate—breast cancer	0.00348	0.00786	CbGbCtD
Enzalutamide—ABCB1—Irinotecan—breast cancer	0.00344	0.00777	CbGbCtD
Enzalutamide—CYP2C9—Fluorouracil—breast cancer	0.0034	0.00769	CbGbCtD
Enzalutamide—ABCB1—Vinblastine—breast cancer	0.00306	0.00691	CbGbCtD
Enzalutamide—CYP3A4—Vinorelbine—breast cancer	0.00297	0.00672	CbGbCtD
Enzalutamide—CYP2D6—Vinblastine—breast cancer	0.00288	0.00651	CbGbCtD
Enzalutamide—CYP3A4—Tamoxifen—breast cancer	0.00268	0.00606	CbGbCtD
Enzalutamide—CYP3A4—Mitoxantrone—breast cancer	0.00262	0.00591	CbGbCtD
Enzalutamide—ABCB1—Docetaxel—breast cancer	0.00252	0.0057	CbGbCtD
Enzalutamide—CYP3A4—Paclitaxel—breast cancer	0.00209	0.00472	CbGbCtD
Enzalutamide—CYP3A4—Irinotecan—breast cancer	0.00206	0.00466	CbGbCtD
Enzalutamide—ABCB1—Doxorubicin—breast cancer	0.00188	0.00425	CbGbCtD
Enzalutamide—CYP3A4—Vinblastine—breast cancer	0.00183	0.00414	CbGbCtD
Enzalutamide—ABCB1—Methotrexate—breast cancer	0.00182	0.00411	CbGbCtD
Enzalutamide—CYP2D6—Doxorubicin—breast cancer	0.00177	0.004	CbGbCtD
Enzalutamide—CYP3A4—Docetaxel—breast cancer	0.00151	0.00341	CbGbCtD
Enzalutamide—Bicalutamide—AR—breast cancer	0.00124	0.401	CrCbGaD
Enzalutamide—CYP3A4—Doxorubicin—breast cancer	0.00113	0.00254	CbGbCtD
Enzalutamide—Nilutamide—AR—breast cancer	0.000801	0.258	CrCbGaD
Enzalutamide—Bicalutamide—CYP2D6—breast cancer	0.00057	0.184	CrCbGaD
Enzalutamide—Bicalutamide—CYP3A4—breast cancer	0.000489	0.158	CrCbGaD
Enzalutamide—ALB—mammary gland—breast cancer	0.000389	0.0701	CbGeAlD
Enzalutamide—AR—nipple—breast cancer	0.000279	0.0504	CbGeAlD
Enzalutamide—CYP2C8—mammary gland—breast cancer	0.000273	0.0493	CbGeAlD
Enzalutamide—CYP2C9—mammary gland—breast cancer	0.000243	0.0438	CbGeAlD
Enzalutamide—AR—epithelium—breast cancer	0.000188	0.0339	CbGeAlD
Enzalutamide—AR—skin of body—breast cancer	0.000179	0.0323	CbGeAlD
Enzalutamide—AR—endometrium—breast cancer	0.000169	0.0304	CbGeAlD
Enzalutamide—ALB—adrenal gland—breast cancer	0.000157	0.0283	CbGeAlD
Enzalutamide—AR—uterus—breast cancer	0.000155	0.028	CbGeAlD
Enzalutamide—AR—pituitary gland—breast cancer	0.000153	0.0275	CbGeAlD
Enzalutamide—AR—adipose tissue—breast cancer	0.000152	0.0274	CbGeAlD
Enzalutamide—AR—female reproductive system—breast cancer	0.00014	0.0252	CbGeAlD
Enzalutamide—CYP2C8—endometrium—breast cancer	0.000136	0.0246	CbGeAlD
Enzalutamide—AR—adrenal gland—breast cancer	0.000136	0.0246	CbGeAlD
Enzalutamide—CYP2B6—skin of body—breast cancer	0.00013	0.0234	CbGeAlD
Enzalutamide—AR—female gonad—breast cancer	0.000127	0.0229	CbGeAlD
Enzalutamide—CYP2C8—pituitary gland—breast cancer	0.000123	0.0223	CbGeAlD
Enzalutamide—AR—endocrine gland—breast cancer	0.000118	0.0213	CbGeAlD
Enzalutamide—CYP2C8—female reproductive system—breast cancer	0.000113	0.0204	CbGeAlD
Enzalutamide—CYP3A5—adipose tissue—breast cancer	0.000111	0.02	CbGeAlD
Enzalutamide—CYP2C19—endocrine gland—breast cancer	0.00011	0.0198	CbGeAlD
Enzalutamide—CYP2B6—female reproductive system—breast cancer	0.000101	0.0183	CbGeAlD
Enzalutamide—CYP2C9—female reproductive system—breast cancer	0.0001	0.0181	CbGeAlD
Enzalutamide—CYP2B6—adrenal gland—breast cancer	9.9e-05	0.0178	CbGeAlD
Enzalutamide—CYP2C8—endocrine gland—breast cancer	9.57e-05	0.0173	CbGeAlD
Enzalutamide—ALB—lymph node—breast cancer	9.41e-05	0.017	CbGeAlD
Enzalutamide—CYP3A5—female gonad—breast cancer	9.28e-05	0.0167	CbGeAlD
Enzalutamide—ABCB1—embryo—breast cancer	8.94e-05	0.0161	CbGeAlD
Enzalutamide—CYP3A5—endocrine gland—breast cancer	8.63e-05	0.0156	CbGeAlD
Enzalutamide—CYP2B6—endocrine gland—breast cancer	8.58e-05	0.0155	CbGeAlD
Enzalutamide—CYP2C9—endocrine gland—breast cancer	8.5e-05	0.0153	CbGeAlD
Enzalutamide—AR—lymph node—breast cancer	8.18e-05	0.0147	CbGeAlD
Enzalutamide—Nervous system disorder—Gemcitabine—breast cancer	7.74e-05	0.000622	CcSEcCtD
Enzalutamide—Urethral disorder—Docetaxel—breast cancer	7.73e-05	0.000621	CcSEcCtD
Enzalutamide—Thrombocytopenia—Gemcitabine—breast cancer	7.73e-05	0.000621	CcSEcCtD
Enzalutamide—Infection—Fluorouracil—breast cancer	7.71e-05	0.000619	CcSEcCtD
Enzalutamide—Diarrhoea—Melphalan—breast cancer	7.7e-05	0.000618	CcSEcCtD
Enzalutamide—Skin disorder—Gemcitabine—breast cancer	7.67e-05	0.000616	CcSEcCtD
Enzalutamide—CYP3A4—female reproductive system—breast cancer	7.66e-05	0.0138	CbGeAlD
Enzalutamide—Rhinitis—Capecitabine—breast cancer	7.65e-05	0.000615	CcSEcCtD
Enzalutamide—Nervous system disorder—Fluorouracil—breast cancer	7.61e-05	0.000611	CcSEcCtD
Enzalutamide—Hot flush—Doxorubicin—breast cancer	7.6e-05	0.000611	CcSEcCtD
Enzalutamide—Thrombocytopenia—Fluorouracil—breast cancer	7.6e-05	0.00061	CcSEcCtD
Enzalutamide—Hypoaesthesia—Capecitabine—breast cancer	7.6e-05	0.00061	CcSEcCtD
Enzalutamide—Dizziness—Tamoxifen—breast cancer	7.6e-05	0.00061	CcSEcCtD
Enzalutamide—Pharyngitis—Capecitabine—breast cancer	7.58e-05	0.000608	CcSEcCtD
Enzalutamide—Urinary tract disorder—Capecitabine—breast cancer	7.54e-05	0.000605	CcSEcCtD
Enzalutamide—Menopausal symptoms—Doxorubicin—breast cancer	7.54e-05	0.000605	CcSEcCtD
Enzalutamide—CYP2D6—female reproductive system—breast cancer	7.53e-05	0.0136	CbGeAlD
Enzalutamide—Oedema peripheral—Capecitabine—breast cancer	7.52e-05	0.000604	CcSEcCtD
Enzalutamide—Diarrhoea—Goserelin—breast cancer	7.51e-05	0.000603	CcSEcCtD
Enzalutamide—Connective tissue disorder—Capecitabine—breast cancer	7.5e-05	0.000602	CcSEcCtD
Enzalutamide—Urethral disorder—Capecitabine—breast cancer	7.48e-05	0.000601	CcSEcCtD
Enzalutamide—Headache—Vinblastine—breast cancer	7.41e-05	0.000595	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Mitoxantrone—breast cancer	7.38e-05	0.000593	CcSEcCtD
Enzalutamide—Insomnia—Irinotecan—breast cancer	7.33e-05	0.000589	CcSEcCtD
Enzalutamide—ABCB1—epithelium—breast cancer	7.3e-05	0.0132	CbGeAlD
Enzalutamide—Paraesthesia—Irinotecan—breast cancer	7.28e-05	0.000584	CcSEcCtD
Enzalutamide—Paraesthesia—Mitoxantrone—breast cancer	7.28e-05	0.000584	CcSEcCtD
Enzalutamide—Vertigo—Paclitaxel—breast cancer	7.28e-05	0.000584	CcSEcCtD
Enzalutamide—Dizziness—Goserelin—breast cancer	7.26e-05	0.000583	CcSEcCtD
Enzalutamide—Leukopenia—Paclitaxel—breast cancer	7.25e-05	0.000582	CcSEcCtD
Enzalutamide—Headache—Tamoxifen—breast cancer	7.2e-05	0.000578	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Gemcitabine—breast cancer	7.19e-05	0.000577	CcSEcCtD
Enzalutamide—Angiopathy—Docetaxel—breast cancer	7.15e-05	0.000574	CcSEcCtD
Enzalutamide—Insomnia—Gemcitabine—breast cancer	7.14e-05	0.000573	CcSEcCtD
Enzalutamide—Paraesthesia—Gemcitabine—breast cancer	7.09e-05	0.000569	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Fluorouracil—breast cancer	7.07e-05	0.000568	CcSEcCtD
Enzalutamide—Asthenia—Vinorelbine—breast cancer	7.05e-05	0.000566	CcSEcCtD
Enzalutamide—Dry skin—Epirubicin—breast cancer	7.05e-05	0.000566	CcSEcCtD
Enzalutamide—Insomnia—Fluorouracil—breast cancer	7.02e-05	0.000564	CcSEcCtD
Enzalutamide—Convulsion—Paclitaxel—breast cancer	7.02e-05	0.000563	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Irinotecan—breast cancer	7e-05	0.000562	CcSEcCtD
Enzalutamide—Hypertension—Paclitaxel—breast cancer	6.99e-05	0.000561	CcSEcCtD
Enzalutamide—Fatigue—Irinotecan—breast cancer	6.99e-05	0.000561	CcSEcCtD
Enzalutamide—Fatigue—Mitoxantrone—breast cancer	6.99e-05	0.000561	CcSEcCtD
Enzalutamide—Paraesthesia—Fluorouracil—breast cancer	6.97e-05	0.00056	CcSEcCtD
Enzalutamide—Pruritus—Vinorelbine—breast cancer	6.95e-05	0.000558	CcSEcCtD
Enzalutamide—Angiopathy—Capecitabine—breast cancer	6.93e-05	0.000556	CcSEcCtD
Enzalutamide—Mental disorder—Docetaxel—breast cancer	6.91e-05	0.000555	CcSEcCtD
Enzalutamide—Arthralgia—Paclitaxel—breast cancer	6.9e-05	0.000554	CcSEcCtD
Enzalutamide—Nasopharyngitis—Epirubicin—breast cancer	6.88e-05	0.000552	CcSEcCtD
Enzalutamide—Headache—Goserelin—breast cancer	6.87e-05	0.000552	CcSEcCtD
Enzalutamide—Anxiety—Paclitaxel—breast cancer	6.87e-05	0.000552	CcSEcCtD
Enzalutamide—CYP2D6—female gonad—breast cancer	6.86e-05	0.0124	CbGeAlD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—breast cancer	6.85e-05	0.00055	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Gemcitabine—breast cancer	6.82e-05	0.000547	CcSEcCtD
Enzalutamide—Fatigue—Gemcitabine—breast cancer	6.81e-05	0.000546	CcSEcCtD
Enzalutamide—Muscular weakness—Epirubicin—breast cancer	6.78e-05	0.000544	CcSEcCtD
Enzalutamide—Asthenia—Thiotepa—breast cancer	6.73e-05	0.000541	CcSEcCtD
Enzalutamide—Diarrhoea—Vinorelbine—breast cancer	6.72e-05	0.00054	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Fluorouracil—breast cancer	6.7e-05	0.000538	CcSEcCtD
Enzalutamide—Mental disorder—Capecitabine—breast cancer	6.69e-05	0.000537	CcSEcCtD
Enzalutamide—Back pain—Docetaxel—breast cancer	6.64e-05	0.000533	CcSEcCtD
Enzalutamide—Neutropenia—Methotrexate—breast cancer	6.64e-05	0.000533	CcSEcCtD
Enzalutamide—Pruritus—Thiotepa—breast cancer	6.64e-05	0.000533	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Methotrexate—breast cancer	6.6e-05	0.00053	CcSEcCtD
Enzalutamide—Infection—Paclitaxel—breast cancer	6.57e-05	0.000527	CcSEcCtD
Enzalutamide—ABCB1—endometrium—breast cancer	6.54e-05	0.0118	CbGeAlD
Enzalutamide—Dry skin—Doxorubicin—breast cancer	6.52e-05	0.000524	CcSEcCtD
Enzalutamide—Dizziness—Vinorelbine—breast cancer	6.5e-05	0.000522	CcSEcCtD
Enzalutamide—Nervous system disorder—Paclitaxel—breast cancer	6.48e-05	0.00052	CcSEcCtD
Enzalutamide—CYP3A4—endocrine gland—breast cancer	6.48e-05	0.0117	CbGeAlD
Enzalutamide—Thrombocytopenia—Paclitaxel—breast cancer	6.47e-05	0.00052	CcSEcCtD
Enzalutamide—Back pain—Capecitabine—breast cancer	6.43e-05	0.000516	CcSEcCtD
Enzalutamide—Diarrhoea—Thiotepa—breast cancer	6.42e-05	0.000516	CcSEcCtD
Enzalutamide—Skin disorder—Paclitaxel—breast cancer	6.42e-05	0.000515	CcSEcCtD
Enzalutamide—Bronchitis—Epirubicin—breast cancer	6.39e-05	0.000513	CcSEcCtD
Enzalutamide—CYP2D6—endocrine gland—breast cancer	6.38e-05	0.0115	CbGeAlD
Enzalutamide—Pneumonia—Methotrexate—breast cancer	6.37e-05	0.000511	CcSEcCtD
Enzalutamide—Nasopharyngitis—Doxorubicin—breast cancer	6.36e-05	0.000511	CcSEcCtD
Enzalutamide—Infestation NOS—Methotrexate—breast cancer	6.33e-05	0.000508	CcSEcCtD
Enzalutamide—Infestation—Methotrexate—breast cancer	6.33e-05	0.000508	CcSEcCtD
Enzalutamide—Muscular weakness—Doxorubicin—breast cancer	6.27e-05	0.000504	CcSEcCtD
Enzalutamide—Neutropenia—Epirubicin—breast cancer	6.21e-05	0.000499	CcSEcCtD
Enzalutamide—Dizziness—Thiotepa—breast cancer	6.21e-05	0.000498	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Epirubicin—breast cancer	6.18e-05	0.000496	CcSEcCtD
Enzalutamide—Headache—Vinorelbine—breast cancer	6.16e-05	0.000494	CcSEcCtD
Enzalutamide—Leukopenia—Docetaxel—breast cancer	6.14e-05	0.000493	CcSEcCtD
Enzalutamide—Pollakiuria—Epirubicin—breast cancer	6.14e-05	0.000493	CcSEcCtD
Enzalutamide—Haematuria—Methotrexate—breast cancer	6.04e-05	0.000485	CcSEcCtD
Enzalutamide—ABCB1—uterus—breast cancer	6.03e-05	0.0109	CbGeAlD
Enzalutamide—Musculoskeletal discomfort—Paclitaxel—breast cancer	6.02e-05	0.000483	CcSEcCtD
Enzalutamide—Insomnia—Paclitaxel—breast cancer	5.98e-05	0.00048	CcSEcCtD
Enzalutamide—Epistaxis—Methotrexate—breast cancer	5.97e-05	0.000479	CcSEcCtD
Enzalutamide—Vertigo—Capecitabine—breast cancer	5.97e-05	0.000479	CcSEcCtD
Enzalutamide—Pneumonia—Epirubicin—breast cancer	5.96e-05	0.000478	CcSEcCtD
Enzalutamide—Leukopenia—Capecitabine—breast cancer	5.95e-05	0.000478	CcSEcCtD
Enzalutamide—Convulsion—Docetaxel—breast cancer	5.95e-05	0.000478	CcSEcCtD
Enzalutamide—Paraesthesia—Paclitaxel—breast cancer	5.94e-05	0.000477	CcSEcCtD
Enzalutamide—Hypertension—Docetaxel—breast cancer	5.93e-05	0.000476	CcSEcCtD
Enzalutamide—Infestation—Epirubicin—breast cancer	5.93e-05	0.000476	CcSEcCtD
Enzalutamide—Infestation NOS—Epirubicin—breast cancer	5.93e-05	0.000476	CcSEcCtD
Enzalutamide—ABCB1—pituitary gland—breast cancer	5.92e-05	0.0107	CbGeAlD
Enzalutamide—Bronchitis—Doxorubicin—breast cancer	5.91e-05	0.000475	CcSEcCtD
Enzalutamide—ABCB1—adipose tissue—breast cancer	5.9e-05	0.0106	CbGeAlD
Enzalutamide—Headache—Thiotepa—breast cancer	5.88e-05	0.000472	CcSEcCtD
Enzalutamide—Arthralgia—Docetaxel—breast cancer	5.84e-05	0.000469	CcSEcCtD
Enzalutamide—Asthenia—Irinotecan—breast cancer	5.81e-05	0.000467	CcSEcCtD
Enzalutamide—Asthenia—Mitoxantrone—breast cancer	5.81e-05	0.000467	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	5.8e-05	0.000466	CcSEcCtD
Enzalutamide—Neutropenia—Doxorubicin—breast cancer	5.75e-05	0.000462	CcSEcCtD
Enzalutamide—Hypertension—Capecitabine—breast cancer	5.74e-05	0.000461	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Doxorubicin—breast cancer	5.71e-05	0.000459	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Paclitaxel—breast cancer	5.71e-05	0.000458	CcSEcCtD
Enzalutamide—Fatigue—Paclitaxel—breast cancer	5.7e-05	0.000458	CcSEcCtD
Enzalutamide—Pollakiuria—Doxorubicin—breast cancer	5.68e-05	0.000456	CcSEcCtD
Enzalutamide—Asthenia—Gemcitabine—breast cancer	5.66e-05	0.000455	CcSEcCtD
Enzalutamide—Arthralgia—Capecitabine—breast cancer	5.66e-05	0.000454	CcSEcCtD
Enzalutamide—Haematuria—Epirubicin—breast cancer	5.65e-05	0.000454	CcSEcCtD
Enzalutamide—Pharyngitis—Methotrexate—breast cancer	5.64e-05	0.000453	CcSEcCtD
Enzalutamide—Anxiety—Capecitabine—breast cancer	5.64e-05	0.000453	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	5.62e-05	0.000451	CcSEcCtD
Enzalutamide—Urinary tract disorder—Methotrexate—breast cancer	5.61e-05	0.000451	CcSEcCtD
Enzalutamide—Epistaxis—Epirubicin—breast cancer	5.59e-05	0.000449	CcSEcCtD
Enzalutamide—Pruritus—Gemcitabine—breast cancer	5.59e-05	0.000448	CcSEcCtD
Enzalutamide—Urethral disorder—Methotrexate—breast cancer	5.57e-05	0.000447	CcSEcCtD
Enzalutamide—Infection—Docetaxel—breast cancer	5.57e-05	0.000447	CcSEcCtD
Enzalutamide—Sinusitis—Epirubicin—breast cancer	5.56e-05	0.000446	CcSEcCtD
Enzalutamide—Diarrhoea—Irinotecan—breast cancer	5.55e-05	0.000445	CcSEcCtD
Enzalutamide—Diarrhoea—Mitoxantrone—breast cancer	5.55e-05	0.000445	CcSEcCtD
Enzalutamide—Pneumonia—Doxorubicin—breast cancer	5.51e-05	0.000443	CcSEcCtD
Enzalutamide—Nervous system disorder—Docetaxel—breast cancer	5.49e-05	0.000441	CcSEcCtD
Enzalutamide—Pruritus—Fluorouracil—breast cancer	5.49e-05	0.000441	CcSEcCtD
Enzalutamide—Thrombocytopenia—Docetaxel—breast cancer	5.49e-05	0.00044	CcSEcCtD
Enzalutamide—Infestation NOS—Doxorubicin—breast cancer	5.48e-05	0.00044	CcSEcCtD
Enzalutamide—Infestation—Doxorubicin—breast cancer	5.48e-05	0.00044	CcSEcCtD
Enzalutamide—Skin disorder—Docetaxel—breast cancer	5.44e-05	0.000437	CcSEcCtD
Enzalutamide—ABCB1—female reproductive system—breast cancer	5.42e-05	0.00978	CbGeAlD
Enzalutamide—Diarrhoea—Gemcitabine—breast cancer	5.4e-05	0.000434	CcSEcCtD
Enzalutamide—Infection—Capecitabine—breast cancer	5.39e-05	0.000433	CcSEcCtD
Enzalutamide—Dizziness—Irinotecan—breast cancer	5.36e-05	0.00043	CcSEcCtD
Enzalutamide—Rhinitis—Epirubicin—breast cancer	5.33e-05	0.000428	CcSEcCtD
Enzalutamide—Nervous system disorder—Capecitabine—breast cancer	5.32e-05	0.000427	CcSEcCtD
Enzalutamide—Diarrhoea—Fluorouracil—breast cancer	5.31e-05	0.000426	CcSEcCtD
Enzalutamide—Thrombocytopenia—Capecitabine—breast cancer	5.31e-05	0.000426	CcSEcCtD
Enzalutamide—Hypoaesthesia—Epirubicin—breast cancer	5.29e-05	0.000425	CcSEcCtD
Enzalutamide—ABCB1—adrenal gland—breast cancer	5.29e-05	0.00954	CbGeAlD
Enzalutamide—Pharyngitis—Epirubicin—breast cancer	5.28e-05	0.000424	CcSEcCtD
Enzalutamide—Skin disorder—Capecitabine—breast cancer	5.27e-05	0.000423	CcSEcCtD
Enzalutamide—Urinary tract disorder—Epirubicin—breast cancer	5.25e-05	0.000422	CcSEcCtD
Enzalutamide—Oedema peripheral—Epirubicin—breast cancer	5.24e-05	0.000421	CcSEcCtD
Enzalutamide—Haematuria—Doxorubicin—breast cancer	5.23e-05	0.00042	CcSEcCtD
Enzalutamide—Connective tissue disorder—Epirubicin—breast cancer	5.23e-05	0.00042	CcSEcCtD
Enzalutamide—Urethral disorder—Epirubicin—breast cancer	5.21e-05	0.000419	CcSEcCtD
Enzalutamide—Epistaxis—Doxorubicin—breast cancer	5.17e-05	0.000415	CcSEcCtD
Enzalutamide—Angiopathy—Methotrexate—breast cancer	5.16e-05	0.000414	CcSEcCtD
Enzalutamide—Sinusitis—Doxorubicin—breast cancer	5.14e-05	0.000413	CcSEcCtD
Enzalutamide—Dizziness—Fluorouracil—breast cancer	5.13e-05	0.000412	CcSEcCtD
Enzalutamide—ABCB1—bone marrow—breast cancer	5.12e-05	0.00923	CbGeAlD
Enzalutamide—Musculoskeletal discomfort—Docetaxel—breast cancer	5.1e-05	0.00041	CcSEcCtD
Enzalutamide—Headache—Mitoxantrone—breast cancer	5.08e-05	0.000408	CcSEcCtD
Enzalutamide—Headache—Irinotecan—breast cancer	5.08e-05	0.000408	CcSEcCtD
Enzalutamide—Insomnia—Docetaxel—breast cancer	5.07e-05	0.000407	CcSEcCtD
Enzalutamide—Paraesthesia—Docetaxel—breast cancer	5.03e-05	0.000404	CcSEcCtD
Enzalutamide—Mental disorder—Methotrexate—breast cancer	4.98e-05	0.0004	CcSEcCtD
Enzalutamide—Headache—Gemcitabine—breast cancer	4.95e-05	0.000397	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Capecitabine—breast cancer	4.94e-05	0.000397	CcSEcCtD
Enzalutamide—Rhinitis—Doxorubicin—breast cancer	4.93e-05	0.000396	CcSEcCtD
Enzalutamide—ABCB1—female gonad—breast cancer	4.93e-05	0.0089	CbGeAlD
Enzalutamide—Insomnia—Capecitabine—breast cancer	4.91e-05	0.000394	CcSEcCtD
Enzalutamide—Hypoaesthesia—Doxorubicin—breast cancer	4.9e-05	0.000393	CcSEcCtD
Enzalutamide—Pharyngitis—Doxorubicin—breast cancer	4.88e-05	0.000392	CcSEcCtD
Enzalutamide—Paraesthesia—Capecitabine—breast cancer	4.87e-05	0.000391	CcSEcCtD
Enzalutamide—Headache—Fluorouracil—breast cancer	4.86e-05	0.00039	CcSEcCtD
Enzalutamide—Urinary tract disorder—Doxorubicin—breast cancer	4.86e-05	0.00039	CcSEcCtD
Enzalutamide—Oedema peripheral—Doxorubicin—breast cancer	4.85e-05	0.000389	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Docetaxel—breast cancer	4.84e-05	0.000388	CcSEcCtD
Enzalutamide—Connective tissue disorder—Doxorubicin—breast cancer	4.84e-05	0.000388	CcSEcCtD
Enzalutamide—Fatigue—Docetaxel—breast cancer	4.83e-05	0.000388	CcSEcCtD
Enzalutamide—Angiopathy—Epirubicin—breast cancer	4.83e-05	0.000387	CcSEcCtD
Enzalutamide—Urethral disorder—Doxorubicin—breast cancer	4.82e-05	0.000387	CcSEcCtD
Enzalutamide—Back pain—Methotrexate—breast cancer	4.79e-05	0.000384	CcSEcCtD
Enzalutamide—Asthenia—Paclitaxel—breast cancer	4.74e-05	0.000381	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Capecitabine—breast cancer	4.68e-05	0.000376	CcSEcCtD
Enzalutamide—Fatigue—Capecitabine—breast cancer	4.68e-05	0.000375	CcSEcCtD
Enzalutamide—Pruritus—Paclitaxel—breast cancer	4.68e-05	0.000375	CcSEcCtD
Enzalutamide—Mental disorder—Epirubicin—breast cancer	4.66e-05	0.000374	CcSEcCtD
Enzalutamide—ABCB1—endocrine gland—breast cancer	4.59e-05	0.00827	CbGeAlD
Enzalutamide—Diarrhoea—Paclitaxel—breast cancer	4.52e-05	0.000363	CcSEcCtD
Enzalutamide—Back pain—Epirubicin—breast cancer	4.48e-05	0.00036	CcSEcCtD
Enzalutamide—Angiopathy—Doxorubicin—breast cancer	4.47e-05	0.000358	CcSEcCtD
Enzalutamide—Vertigo—Methotrexate—breast cancer	4.45e-05	0.000357	CcSEcCtD
Enzalutamide—Leukopenia—Methotrexate—breast cancer	4.43e-05	0.000356	CcSEcCtD
Enzalutamide—Dizziness—Paclitaxel—breast cancer	4.37e-05	0.000351	CcSEcCtD
Enzalutamide—Mental disorder—Doxorubicin—breast cancer	4.31e-05	0.000346	CcSEcCtD
Enzalutamide—Convulsion—Methotrexate—breast cancer	4.29e-05	0.000344	CcSEcCtD
Enzalutamide—Arthralgia—Methotrexate—breast cancer	4.21e-05	0.000338	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	4.18e-05	0.000336	CcSEcCtD
Enzalutamide—Vertigo—Epirubicin—breast cancer	4.16e-05	0.000334	CcSEcCtD
Enzalutamide—Leukopenia—Epirubicin—breast cancer	4.14e-05	0.000333	CcSEcCtD
Enzalutamide—Back pain—Doxorubicin—breast cancer	4.14e-05	0.000333	CcSEcCtD
Enzalutamide—Headache—Paclitaxel—breast cancer	4.14e-05	0.000332	CcSEcCtD
Enzalutamide—Asthenia—Docetaxel—breast cancer	4.02e-05	0.000323	CcSEcCtD
Enzalutamide—Convulsion—Epirubicin—breast cancer	4.01e-05	0.000322	CcSEcCtD
Enzalutamide—Infection—Methotrexate—breast cancer	4.01e-05	0.000322	CcSEcCtD
Enzalutamide—Hypertension—Epirubicin—breast cancer	4e-05	0.000321	CcSEcCtD
Enzalutamide—Pruritus—Docetaxel—breast cancer	3.96e-05	0.000318	CcSEcCtD
Enzalutamide—Nervous system disorder—Methotrexate—breast cancer	3.96e-05	0.000318	CcSEcCtD
Enzalutamide—Thrombocytopenia—Methotrexate—breast cancer	3.95e-05	0.000317	CcSEcCtD
Enzalutamide—Arthralgia—Epirubicin—breast cancer	3.94e-05	0.000316	CcSEcCtD
Enzalutamide—Anxiety—Epirubicin—breast cancer	3.93e-05	0.000315	CcSEcCtD
Enzalutamide—Skin disorder—Methotrexate—breast cancer	3.92e-05	0.000315	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	3.91e-05	0.000314	CcSEcCtD
Enzalutamide—Asthenia—Capecitabine—breast cancer	3.89e-05	0.000312	CcSEcCtD
Enzalutamide—Vertigo—Doxorubicin—breast cancer	3.85e-05	0.000309	CcSEcCtD
Enzalutamide—Pruritus—Capecitabine—breast cancer	3.84e-05	0.000308	CcSEcCtD
Enzalutamide—Leukopenia—Doxorubicin—breast cancer	3.83e-05	0.000308	CcSEcCtD
Enzalutamide—Diarrhoea—Docetaxel—breast cancer	3.83e-05	0.000308	CcSEcCtD
Enzalutamide—Infection—Epirubicin—breast cancer	3.75e-05	0.000301	CcSEcCtD
Enzalutamide—Convulsion—Doxorubicin—breast cancer	3.71e-05	0.000298	CcSEcCtD
Enzalutamide—Diarrhoea—Capecitabine—breast cancer	3.71e-05	0.000298	CcSEcCtD
Enzalutamide—Nervous system disorder—Epirubicin—breast cancer	3.71e-05	0.000298	CcSEcCtD
Enzalutamide—Dizziness—Docetaxel—breast cancer	3.7e-05	0.000297	CcSEcCtD
Enzalutamide—Thrombocytopenia—Epirubicin—breast cancer	3.7e-05	0.000297	CcSEcCtD
Enzalutamide—Hypertension—Doxorubicin—breast cancer	3.7e-05	0.000297	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Methotrexate—breast cancer	3.68e-05	0.000295	CcSEcCtD
Enzalutamide—Skin disorder—Epirubicin—breast cancer	3.67e-05	0.000295	CcSEcCtD
Enzalutamide—Insomnia—Methotrexate—breast cancer	3.65e-05	0.000293	CcSEcCtD
Enzalutamide—Arthralgia—Doxorubicin—breast cancer	3.65e-05	0.000293	CcSEcCtD
Enzalutamide—Anxiety—Doxorubicin—breast cancer	3.63e-05	0.000292	CcSEcCtD
Enzalutamide—Paraesthesia—Methotrexate—breast cancer	3.63e-05	0.000291	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	3.62e-05	0.000291	CcSEcCtD
Enzalutamide—Dizziness—Capecitabine—breast cancer	3.59e-05	0.000288	CcSEcCtD
Enzalutamide—Headache—Docetaxel—breast cancer	3.51e-05	0.000282	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Methotrexate—breast cancer	3.49e-05	0.00028	CcSEcCtD
Enzalutamide—Fatigue—Methotrexate—breast cancer	3.48e-05	0.000279	CcSEcCtD
Enzalutamide—Infection—Doxorubicin—breast cancer	3.47e-05	0.000279	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Epirubicin—breast cancer	3.44e-05	0.000276	CcSEcCtD
Enzalutamide—Nervous system disorder—Doxorubicin—breast cancer	3.43e-05	0.000275	CcSEcCtD
Enzalutamide—Thrombocytopenia—Doxorubicin—breast cancer	3.42e-05	0.000275	CcSEcCtD
Enzalutamide—Insomnia—Epirubicin—breast cancer	3.42e-05	0.000274	CcSEcCtD
Enzalutamide—Headache—Capecitabine—breast cancer	3.4e-05	0.000273	CcSEcCtD
Enzalutamide—Skin disorder—Doxorubicin—breast cancer	3.4e-05	0.000273	CcSEcCtD
Enzalutamide—Paraesthesia—Epirubicin—breast cancer	3.39e-05	0.000272	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Epirubicin—breast cancer	3.26e-05	0.000262	CcSEcCtD
Enzalutamide—Fatigue—Epirubicin—breast cancer	3.26e-05	0.000262	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Doxorubicin—breast cancer	3.19e-05	0.000256	CcSEcCtD
Enzalutamide—ABCB1—lymph node—breast cancer	3.17e-05	0.00572	CbGeAlD
Enzalutamide—Insomnia—Doxorubicin—breast cancer	3.16e-05	0.000254	CcSEcCtD
Enzalutamide—Paraesthesia—Doxorubicin—breast cancer	3.14e-05	0.000252	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Doxorubicin—breast cancer	3.02e-05	0.000242	CcSEcCtD
Enzalutamide—Fatigue—Doxorubicin—breast cancer	3.01e-05	0.000242	CcSEcCtD
Enzalutamide—Asthenia—Methotrexate—breast cancer	2.9e-05	0.000233	CcSEcCtD
Enzalutamide—Pruritus—Methotrexate—breast cancer	2.86e-05	0.000229	CcSEcCtD
Enzalutamide—Diarrhoea—Methotrexate—breast cancer	2.76e-05	0.000222	CcSEcCtD
Enzalutamide—Asthenia—Epirubicin—breast cancer	2.71e-05	0.000218	CcSEcCtD
Enzalutamide—Pruritus—Epirubicin—breast cancer	2.67e-05	0.000215	CcSEcCtD
Enzalutamide—Dizziness—Methotrexate—breast cancer	2.67e-05	0.000214	CcSEcCtD
Enzalutamide—Diarrhoea—Epirubicin—breast cancer	2.59e-05	0.000208	CcSEcCtD
Enzalutamide—Headache—Methotrexate—breast cancer	2.53e-05	0.000203	CcSEcCtD
Enzalutamide—Asthenia—Doxorubicin—breast cancer	2.51e-05	0.000201	CcSEcCtD
Enzalutamide—Dizziness—Epirubicin—breast cancer	2.5e-05	0.000201	CcSEcCtD
Enzalutamide—Pruritus—Doxorubicin—breast cancer	2.47e-05	0.000199	CcSEcCtD
Enzalutamide—Diarrhoea—Doxorubicin—breast cancer	2.39e-05	0.000192	CcSEcCtD
Enzalutamide—Headache—Epirubicin—breast cancer	2.37e-05	0.00019	CcSEcCtD
Enzalutamide—Dizziness—Doxorubicin—breast cancer	2.31e-05	0.000186	CcSEcCtD
Enzalutamide—Headache—Doxorubicin—breast cancer	2.19e-05	0.000176	CcSEcCtD
Enzalutamide—ALB—Hemostasis—VEGFA—breast cancer	2.82e-06	3.88e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—GSTP1—breast cancer	2.82e-06	3.88e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—COMT—breast cancer	2.81e-06	3.88e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—NAT2—breast cancer	2.81e-06	3.88e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—ERCC2—breast cancer	2.81e-06	3.87e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	2.81e-06	3.87e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—GSTP1—breast cancer	2.8e-06	3.86e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—HMOX1—breast cancer	2.78e-06	3.83e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—SLC2A1—breast cancer	2.77e-06	3.82e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—NQO1—breast cancer	2.77e-06	3.82e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—ITPR1—breast cancer	2.77e-06	3.82e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—HSP90AA1—breast cancer	2.77e-06	3.81e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—HMOX1—breast cancer	2.76e-06	3.81e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—NCOA1—breast cancer	2.76e-06	3.8e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—ITPR1—breast cancer	2.76e-06	3.8e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—SLC2A1—breast cancer	2.75e-06	3.79e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—NQO1—breast cancer	2.75e-06	3.79e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—STK11—breast cancer	2.72e-06	3.74e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CYP19A1—breast cancer	2.72e-06	3.74e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CYP3A4—breast cancer	2.7e-06	3.73e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—MTHFR—breast cancer	2.7e-06	3.72e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	2.69e-06	3.71e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—NCOA1—breast cancer	2.69e-06	3.71e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CYP3A4—breast cancer	2.68e-06	3.69e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	2.67e-06	3.68e-05	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—MAPK3—breast cancer	2.67e-06	3.67e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—ABCB1—breast cancer	2.67e-06	3.67e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CYP1B1—breast cancer	2.66e-06	3.66e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CYP19A1—breast cancer	2.65e-06	3.65e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—STK11—breast cancer	2.65e-06	3.65e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—ABCB1—breast cancer	2.65e-06	3.65e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—MTHFR—breast cancer	2.64e-06	3.64e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CYP1B1—breast cancer	2.64e-06	3.63e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—TYMS—breast cancer	2.62e-06	3.61e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—HSP90AA1—breast cancer	2.61e-06	3.59e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—TYMS—breast cancer	2.6e-06	3.59e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PLA2G4A—breast cancer	2.59e-06	3.57e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—NCOR1—breast cancer	2.59e-06	3.57e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—GSTM1—breast cancer	2.59e-06	3.57e-05	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—TGFB1—breast cancer	2.59e-06	3.57e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—HSP90AA1—breast cancer	2.58e-06	3.56e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PLA2G4A—breast cancer	2.57e-06	3.55e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—NCOR1—breast cancer	2.57e-06	3.55e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—GSTM1—breast cancer	2.57e-06	3.55e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.55e-06	3.51e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—NCOA1—breast cancer	2.54e-06	3.49e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—COMT—breast cancer	2.53e-06	3.48e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—GSTP1—breast cancer	2.51e-06	3.46e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—NCOA1—breast cancer	2.51e-06	3.46e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—STK11—breast cancer	2.5e-06	3.44e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CYP19A1—breast cancer	2.5e-06	3.44e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—CAV1—breast cancer	2.49e-06	3.43e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—HMOX1—breast cancer	2.48e-06	3.42e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—GPX1—breast cancer	2.48e-06	3.42e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—STK11—breast cancer	2.48e-06	3.41e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CYP19A1—breast cancer	2.48e-06	3.41e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—ITPR1—breast cancer	2.47e-06	3.41e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—MED12—breast cancer	2.47e-06	3.4e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—DPYD—breast cancer	2.47e-06	3.4e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—COMT—breast cancer	2.47e-06	3.4e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—GPX1—breast cancer	2.46e-06	3.4e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—GSTP1—breast cancer	2.45e-06	3.38e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CYP1A1—breast cancer	2.45e-06	3.38e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CYP1A1—breast cancer	2.44e-06	3.36e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—CAV1—breast cancer	2.44e-06	3.36e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—ERCC2—breast cancer	2.43e-06	3.35e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ALDOA—breast cancer	2.43e-06	3.35e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—HMOX1—breast cancer	2.42e-06	3.34e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—ERCC2—breast cancer	2.42e-06	3.33e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—ITPR1—breast cancer	2.41e-06	3.33e-05	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—KRAS—breast cancer	2.4e-06	3.3e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—ABCB1—breast cancer	2.38e-06	3.28e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—NCOA3—breast cancer	2.36e-06	3.25e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—SLC2A2—breast cancer	2.34e-06	3.23e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—TYMS—breast cancer	2.34e-06	3.22e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.33e-06	3.21e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—COMT—breast cancer	2.32e-06	3.2e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—GSTP1—breast cancer	2.31e-06	3.19e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PLA2G4A—breast cancer	2.31e-06	3.18e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—NCOR1—breast cancer	2.31e-06	3.18e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—GSTM1—breast cancer	2.31e-06	3.18e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—COMT—breast cancer	2.3e-06	3.17e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ABCG2—breast cancer	2.29e-06	3.16e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—MTR—breast cancer	2.29e-06	3.16e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CPT1A—breast cancer	2.29e-06	3.16e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—GSTP1—breast cancer	2.29e-06	3.16e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—MTHFR—breast cancer	2.29e-06	3.15e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—TYMS—breast cancer	2.28e-06	3.14e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—HMOX1—breast cancer	2.28e-06	3.14e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—ITPR1—breast cancer	2.28e-06	3.14e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—MTHFR—breast cancer	2.27e-06	3.13e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PIK3CG—breast cancer	2.27e-06	3.13e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—HMOX1—breast cancer	2.26e-06	3.12e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—ITPR1—breast cancer	2.26e-06	3.11e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—NCOR1—breast cancer	2.26e-06	3.11e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PLA2G4A—breast cancer	2.26e-06	3.11e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—GSTM1—breast cancer	2.26e-06	3.11e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—HPGDS—breast cancer	2.25e-06	3.1e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—HBA1—breast cancer	2.23e-06	3.08e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PIK3CG—breast cancer	2.22e-06	3.06e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—GPX1—breast cancer	2.21e-06	3.05e-05	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—PIK3CA—breast cancer	2.2e-06	3.03e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CYP1A1—breast cancer	2.19e-06	3.02e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—ABCB1—breast cancer	2.19e-06	3.02e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ACHE—breast cancer	2.18e-06	3.01e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GSTT1—breast cancer	2.18e-06	3.01e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—ERCC2—breast cancer	2.17e-06	2.99e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—ABCB1—breast cancer	2.17e-06	2.99e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—GPX1—breast cancer	2.16e-06	2.98e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—TYMS—breast cancer	2.15e-06	2.96e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CYP1A1—breast cancer	2.14e-06	2.95e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—TYMS—breast cancer	2.13e-06	2.94e-05	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—TP53—breast cancer	2.13e-06	2.94e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PLA2G4A—breast cancer	2.13e-06	2.93e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—NCOR1—breast cancer	2.13e-06	2.93e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—GSTM1—breast cancer	2.13e-06	2.93e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—ERCC2—breast cancer	2.12e-06	2.92e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CAV1—breast cancer	2.11e-06	2.91e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—NCOR1—breast cancer	2.11e-06	2.9e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PLA2G4A—breast cancer	2.11e-06	2.9e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—GSTM1—breast cancer	2.11e-06	2.9e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CAV1—breast cancer	2.1e-06	2.89e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CYP17A1—breast cancer	2.06e-06	2.85e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PTGS1—breast cancer	2.04e-06	2.82e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ENO1—breast cancer	2.04e-06	2.82e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—MTHFR—breast cancer	2.04e-06	2.81e-05	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—HRAS—breast cancer	2.04e-06	2.81e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—GPX1—breast cancer	2.04e-06	2.8e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—GPX1—breast cancer	2.02e-06	2.78e-05	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—AKT1—breast cancer	2.02e-06	2.78e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.02e-06	2.78e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CYP1A1—breast cancer	2.01e-06	2.78e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2e-06	2.76e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CYP2D6—breast cancer	2e-06	2.76e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—ERCC2—breast cancer	2e-06	2.75e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CYP1A1—breast cancer	2e-06	2.75e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PIK3CD—breast cancer	2e-06	2.75e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—MTHFR—breast cancer	1.99e-06	2.75e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—ERCC2—breast cancer	1.98e-06	2.73e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—ALB—breast cancer	1.97e-06	2.72e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—NCOA2—breast cancer	1.97e-06	2.71e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PIK3CD—breast cancer	1.95e-06	2.69e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—ALB—breast cancer	1.93e-06	2.65e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PIK3CG—breast cancer	1.92e-06	2.65e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PIK3CG—breast cancer	1.91e-06	2.63e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—FASN—breast cancer	1.91e-06	2.63e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—BCHE—breast cancer	1.9e-06	2.62e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—NOS3—breast cancer	1.88e-06	2.6e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CAV1—breast cancer	1.88e-06	2.6e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—MTHFR—breast cancer	1.88e-06	2.59e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—SLC5A5—breast cancer	1.88e-06	2.59e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—MTHFR—breast cancer	1.86e-06	2.57e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—NOS3—breast cancer	1.84e-06	2.54e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CAV1—breast cancer	1.84e-06	2.53e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—NQO1—breast cancer	1.81e-06	2.5e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—SLC2A1—breast cancer	1.81e-06	2.5e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.8e-06	2.48e-05	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—AKT1—breast cancer	1.8e-06	2.48e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PIK3CB—breast cancer	1.74e-06	2.4e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CYP1B1—breast cancer	1.74e-06	2.39e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CAV1—breast cancer	1.73e-06	2.39e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PTGS2—breast cancer	1.72e-06	2.38e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CAV1—breast cancer	1.72e-06	2.37e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PIK3CG—breast cancer	1.72e-06	2.36e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.7e-06	2.35e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PIK3CB—breast cancer	1.7e-06	2.34e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PIK3CD—breast cancer	1.69e-06	2.33e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PTGS2—breast cancer	1.68e-06	2.32e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PIK3CD—breast cancer	1.68e-06	2.32e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PIK3CG—breast cancer	1.67e-06	2.31e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—ALB—breast cancer	1.67e-06	2.3e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—NCOA1—breast cancer	1.66e-06	2.28e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.64e-06	2.26e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CYP19A1—breast cancer	1.63e-06	2.25e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—STK11—breast cancer	1.63e-06	2.25e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—NOS3—breast cancer	1.6e-06	2.2e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—NOS3—breast cancer	1.59e-06	2.19e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PIK3CG—breast cancer	1.58e-06	2.17e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PIK3CG—breast cancer	1.56e-06	2.16e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—COMT—breast cancer	1.52e-06	2.09e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GSTP1—breast cancer	1.51e-06	2.08e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PIK3CD—breast cancer	1.51e-06	2.08e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PTEN—breast cancer	1.5e-06	2.07e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—HMOX1—breast cancer	1.49e-06	2.05e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—ALB—breast cancer	1.49e-06	2.05e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ITPR1—breast cancer	1.49e-06	2.05e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PIK3CB—breast cancer	1.47e-06	2.03e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PIK3CD—breast cancer	1.47e-06	2.03e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PTEN—breast cancer	1.47e-06	2.02e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PIK3CB—breast cancer	1.46e-06	2.02e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PTGS2—breast cancer	1.46e-06	2.01e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—ALB—breast cancer	1.45e-06	2e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PTGS2—breast cancer	1.45e-06	2e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ABCB1—breast cancer	1.43e-06	1.97e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—NOS3—breast cancer	1.42e-06	1.96e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—TYMS—breast cancer	1.41e-06	1.94e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—NOS3—breast cancer	1.39e-06	1.92e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GSTM1—breast cancer	1.39e-06	1.91e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.39e-06	1.91e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—NCOR1—breast cancer	1.39e-06	1.91e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PIK3CD—breast cancer	1.39e-06	1.91e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PIK3CD—breast cancer	1.38e-06	1.9e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—ALB—breast cancer	1.37e-06	1.89e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—ALB—breast cancer	1.36e-06	1.87e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GPX1—breast cancer	1.33e-06	1.83e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CYP1A1—breast cancer	1.32e-06	1.82e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PIK3CB—breast cancer	1.31e-06	1.81e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—NOS3—breast cancer	1.31e-06	1.81e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ERCC2—breast cancer	1.31e-06	1.8e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PTGS2—breast cancer	1.3e-06	1.79e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—NOS3—breast cancer	1.3e-06	1.79e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PIK3CB—breast cancer	1.28e-06	1.77e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PTEN—breast cancer	1.27e-06	1.75e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PTGS2—breast cancer	1.27e-06	1.75e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PTEN—breast cancer	1.27e-06	1.74e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—MTHFR—breast cancer	1.23e-06	1.69e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PIK3CB—breast cancer	1.21e-06	1.67e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PIK3CB—breast cancer	1.2e-06	1.65e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PTGS2—breast cancer	1.2e-06	1.65e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PTGS2—breast cancer	1.19e-06	1.64e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PTEN—breast cancer	1.14e-06	1.57e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CAV1—breast cancer	1.13e-06	1.56e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PTEN—breast cancer	1.11e-06	1.53e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PIK3CA—breast cancer	1.06e-06	1.46e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PTEN—breast cancer	1.04e-06	1.44e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PIK3CA—breast cancer	1.04e-06	1.43e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PTEN—breast cancer	1.04e-06	1.43e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PIK3CG—breast cancer	1.03e-06	1.42e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PIK3CD—breast cancer	9.07e-07	1.25e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PIK3CA—breast cancer	8.98e-07	1.24e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ALB—breast cancer	8.95e-07	1.23e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PIK3CA—breast cancer	8.93e-07	1.23e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—AKT1—breast cancer	8.66e-07	1.19e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—NOS3—breast cancer	8.56e-07	1.18e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—AKT1—breast cancer	8.47e-07	1.17e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PIK3CA—breast cancer	8.01e-07	1.1e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PIK3CB—breast cancer	7.91e-07	1.09e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PTGS2—breast cancer	7.83e-07	1.08e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PIK3CA—breast cancer	7.82e-07	1.08e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PIK3CA—breast cancer	7.37e-07	1.02e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—AKT1—breast cancer	7.33e-07	1.01e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PIK3CA—breast cancer	7.31e-07	1.01e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—AKT1—breast cancer	7.29e-07	1e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PTEN—breast cancer	6.83e-07	9.41e-06	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—AKT1—breast cancer	6.55e-07	9.02e-06	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—AKT1—breast cancer	6.39e-07	8.81e-06	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—AKT1—breast cancer	6.02e-07	8.3e-06	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—AKT1—breast cancer	5.97e-07	8.23e-06	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PIK3CA—breast cancer	4.82e-07	6.64e-06	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—AKT1—breast cancer	3.94e-07	5.43e-06	CbGpPWpGaD
